Rhythm Pharmaceuticals, Inc. (RYTM)
101.02
+3.56
(+3.65%)
USD |
NASDAQ |
Jan 09, 16:00
100.78
-0.24
(-0.24%)
After-Hours: 20:00
Rhythm Pharmaceuticals Research and Development Expense (Quarterly): 45.92M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.466B |
| Gilead Sciences, Inc. | 1.334B |
| Johnson & Johnson | 3.693B |
| ACADIA Pharmaceuticals, Inc. | 87.83M |
| Geron Corp. | 21.07M |